SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-000283
Filing Date
2019-01-03
Accepted
2019-01-03 16:20:18
Documents
1
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4044
  Complete submission text file 0000899243-19-000283.txt   5459
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O MORNINGSIDE TECHNOLOGY ADVISORY, LLC 1188 CENTRE STREET NEWTON CENTRE MA 02459
Business Address
O'Brien Stephanie Monaghan (Reporting) CIK: 0001720907 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 19505695